Skip to main content

Table 2 Correlation between age, MMSE, and biomarker levels for the diagnostic groupsa

From: The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

 

Synaptotagmin, 215–223

Synaptotagmin, 238–245

Sample set I, control (N = 17)

 Age

N.S.

N.S.

 MMSE

N.S.

N.S.

 Amyloid-β1–42 (ng/L)

rho = 0.515, P = 0.04

N.S.

 Total tau (ng/L)

rho = 0.739, P = 0.001

rho = 0.749, P = 0.001

 Phosphorylated tau (ng/L)

rho = 0.770, P = 0003

rho = 0.708, P = 0.001

 Synaptotagmin, 215–223

rho = 0.971, P < 0.00001

 Synaptotagmin, 238–245

rho = 0.971, P < 0.00001

Alzheimer’s disease dementia (N = 17)

 Age

N.S.

N.S.

 MMSE

N.S.

N.S.

 Amyloid-β1–42 (ng/L)

N.S.

N.S.

 Total tau (ng/L)

rho = 0.540, P = 0.03

rho = 0.610, P = 0.009

 Phosphorylated tau (ng/L)

rho = 0.586, P = 0.01

rho = 0.656, P = 0.004

 Synaptotagmin, 215–223

rho = 0.980, P < 0.00001

 Synaptotagmin, 238–245

rho = 0.980, P < 0.00001

Sample set II, control (N = 36)

 Age

N.S.

N.S.

 MMSE

N.S.

N.S.

 Amyloid-β1–42 (ng/L)

rho = 0.381, P = 0.02

rho = 0.348, P = 0.04

 Total tau (ng/L)

rho = 0.641, P = 0.00003

rho = 0.633, P = 0.00004

 Phosphorylated tau (ng/L)

rho = 0.687, P < 0.00001

rho = 0.683, P < 0.00001

 Synaptotagmin, 215–223

rho = 0.995, P < 0.00001

 Synaptotagmin, 238–245

rho = 0.995, P < 0.00001

MCI-AD (N = 18)

 Age

N.S.

N.S.

 MMSE

N.S.

N.S.

 Amyloid-β1–42 (ng/L)

N.S.

N.S.

 Total tau (ng/L)

N.S.

N.S.

 Phosphorylated tau (ng/L)

N.S.

N.S.

 Synaptotagmin, 215–223

rho = 0.988, P < 0.00001

 Synaptotagmin, 238–245

rho = 0.988, P < 0.00001

Alzheimer’s disease dementia (N = 24)

 Age

N.S.

N.S.

 MMSE

N.S.

N.S.

 Amyloid-β1–42 (ng/L)

N.S.

N.S.

 Total tau (ng/L)

rho = 0.655, P = 0.001

rho = 0.675, P = 0.0003

 Phosphorylated tau (ng/L)

rho = 0.653, P = 001

rho = 0.673, P = 0.0003

 Synaptotagmin, 215–223

rho = 0.995, P < 0.00001

 Synaptotagmin, 238–245

rho = 0.995, P < 0.00001

  1. aCorrelations presented by the Spearman’s rank correlation coefficient (rho). Nonsignificant (N.S., P > 0.05) correlations were not reported
  2. MCI-AD mild cognitive impairment due to Alzheimer’s disease, MMSE Mini-Mental State Examination